DK1387837T3 - Hidtil ukendte azol- eller triazolderivater, fremgangsmåden til deres fremstilling og deres anvendelse som antimykotiske lægemidler - Google Patents

Hidtil ukendte azol- eller triazolderivater, fremgangsmåden til deres fremstilling og deres anvendelse som antimykotiske lægemidler

Info

Publication number
DK1387837T3
DK1387837T3 DK02730383T DK02730383T DK1387837T3 DK 1387837 T3 DK1387837 T3 DK 1387837T3 DK 02730383 T DK02730383 T DK 02730383T DK 02730383 T DK02730383 T DK 02730383T DK 1387837 T3 DK1387837 T3 DK 1387837T3
Authority
DK
Denmark
Prior art keywords
sup
preparation
triazole derivatives
antimycotic drugs
new azole
Prior art date
Application number
DK02730383T
Other languages
Danish (da)
English (en)
Inventor
Didier Babin
John Weston
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1387837T3 publication Critical patent/DK1387837T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK02730383T 2001-05-04 2002-05-02 Hidtil ukendte azol- eller triazolderivater, fremgangsmåden til deres fremstilling og deres anvendelse som antimykotiske lægemidler DK1387837T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0105959A FR2824324B1 (fr) 2001-05-04 2001-05-04 Nouveaux derives d'azole ou de triazole, leur procede de preparation et leur application comme medicaments anti-fongiques

Publications (1)

Publication Number Publication Date
DK1387837T3 true DK1387837T3 (da) 2005-11-14

Family

ID=8862967

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02730383T DK1387837T3 (da) 2001-05-04 2002-05-02 Hidtil ukendte azol- eller triazolderivater, fremgangsmåden til deres fremstilling og deres anvendelse som antimykotiske lægemidler

Country Status (10)

Country Link
US (1) US6960600B2 (es)
EP (1) EP1387837B1 (es)
JP (1) JP4587641B2 (es)
AT (1) ATE300530T1 (es)
DE (1) DE60205239T2 (es)
DK (1) DK1387837T3 (es)
ES (1) ES2243725T3 (es)
FR (1) FR2824324B1 (es)
PT (1) PT1387837E (es)
WO (1) WO2002090350A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE516263T1 (de) 2002-05-16 2011-07-15 Sunovion Pharmaceuticals Inc Amine, die einen säugetier-anandamidtransporter hemmen; und verfahren zu deren verwendung
KR100572996B1 (ko) * 2003-08-12 2006-04-25 한국화학연구원 불소화 비닐 에테르 측쇄기를 갖는 아졸계 살균제 화합물및 그의 제조방법
US8188085B2 (en) * 2008-08-12 2012-05-29 Merck Sharp & Dohme Corp. Antifungal agents
US9512087B2 (en) * 2011-06-15 2016-12-06 Council For Scientific & Industrial Research Hybrid molecules containing pharmacophores of fluconazole as antifungal agents and their preparation
WO2015155738A2 (en) 2014-04-09 2015-10-15 Christopher Rudd Use of gsk-3 inhibitors or activators which modulate pd-1 or t-bet expression to modulate t cell immunity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3039087A1 (de) * 1980-10-16 1982-05-19 Hoechst Ag, 6000 Frankfurt 1-(1,3-dioxolan-2-ylmethyl)-azole, ihre salze, verfahren zu ihrer herstellung und ihre verwendung
DE3308554A1 (de) * 1983-03-10 1984-09-13 Hoechst Ag, 6230 Frankfurt 1-/1,3-dioxolan-2-ylmethyl)-azole, ihre salze, verfahren zu ihrer herstellung und ihre verwendung
AR020707A1 (es) * 1998-10-06 2002-05-22 Aventis Pharma Sa Derivados de 2-[3-fenil-2-propenil]-1,2,3,4-tetrahidro-isoquinolina, su procedimiento de preparacion y su aplicacion como fungicidas
FR2807434B1 (fr) * 2000-04-05 2002-10-18 Hoechst Marion Roussel Inc Nouveaux derives de la 1,2,3,4-tetrahydroisoquinoleine, leur procede de preparation et leur application comme fongicides

Also Published As

Publication number Publication date
FR2824324B1 (fr) 2003-08-15
US20040192922A1 (en) 2004-09-30
EP1387837A1 (fr) 2004-02-11
US6960600B2 (en) 2005-11-01
DE60205239D1 (de) 2005-09-01
EP1387837B1 (fr) 2005-07-27
FR2824324A1 (fr) 2002-11-08
JP2004532242A (ja) 2004-10-21
ES2243725T3 (es) 2005-12-01
JP4587641B2 (ja) 2010-11-24
DE60205239T2 (de) 2006-05-24
ATE300530T1 (de) 2005-08-15
PT1387837E (pt) 2005-10-31
WO2002090350A1 (fr) 2002-11-14

Similar Documents

Publication Publication Date Title
MY143599A (en) Pyrazole derivatives, compositions containing such compounds and methods of use
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
CA2441313A1 (en) New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
NO20042635L (no) 5-Sulfanyl-ñH-1,2,4-triazol-derivater og deres anvendelse som medisin
NO20041879L (no) Polymorf form av rimonabant, fremgangsmate for fremstilling derav og farmasoytisk preparat inneholdende det samme.
NO20022202D0 (no) 5-aryl-1H-1,2,4-triazol forbindelser som inhibitorer av cyclooksygenase-2 og farmasöytiske preparater inneholdende disse
MY136430A (en) N-adamantylmethyl derivatives, pharmaceutical compositions containing them and processes for their preparation
GB0124933D0 (en) Chemical compounds
MXPA03010201A (es) Derivados de 2-piridin-ciclohexan-1,4-diamina sustituidos.
ATE516275T1 (de) Microbiozide (z.b. fungizide) 1,2,3- triazolderivate
DK1506185T3 (da) Forbindelser og deres anvendelse som 5-HT-inhibitorer
MXPA03006224A (es) Inhibidores de cruzipaina y otras proteasas de cisteina.
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
AP2002002616A0 (en) Antidibetic agents
WO2003053971A8 (en) Pyridoquinoxaline antivirals
SE0101038D0 (sv) Novel compounds
AU2002339192A1 (en) 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors
WO2003054001A3 (fr) Procede de preparation de derives d'echinocandines et leurs compositions
DK1387837T3 (da) Hidtil ukendte azol- eller triazolderivater, fremgangsmåden til deres fremstilling og deres anvendelse som antimykotiske lægemidler
ATE389405T1 (de) Fexofenadine hydrochlorid polymorph
AU2002248531A1 (en) Pyrazolopyriadine derivatives
SE0202693D0 (sv) Compounds
DK1387841T3 (da) Hidtil ukendt azol- eller triazolderivater, fremgangsmåde til deres fremstilling og deres anvendelse som fungicider
SE0202692D0 (sv) Compounds
SE0102809D0 (sv) Novel compounds